During the last session, ImmunityBio Inc (NASDAQ:IBRX)’s traded shares were 28.58 million, with the beta value of the company hitting 0.63. At the end of
In the last trading session, 3.46 million shares of the ImmunityBio Inc (NASDAQ:IBRX) were traded, and its beta was 0.63. Most recently the company’s share
ImmunityBio Inc (NASDAQ:IBRX)’s traded shares stood at 2.94 million during the last session, with the company’s beta value hitting 0.63. At the close of trading,
In the last trading session, 1.79 million ImmunityBio Inc (NASDAQ:IBRX) shares changed hands as the company’s beta touched 0.75. With the company’s per share price
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
